Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Forte Biosciences Inc FBRX

Healthcare Biotechnology
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases. The Company is advancing its product candidate, FB-102, which is a proprietary molecule with potentially broad autoimmune applications, including in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA). The Company’s FB-102 program... see more

Recent & Breaking News (NDAQ:FBRX)

Forte Biosciences to Host R&D Day December 3, 2024

Business Wire 13 hours ago

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Business Wire 5 days ago

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

Business Wire 11 days ago

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Business Wire August 14, 2024

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Business Wire May 17, 2024

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

Business Wire May 13, 2024

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Business Wire March 18, 2024

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Business Wire December 1, 2023

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Business Wire November 13, 2023

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company's Upcoming Annual Meeting

Business Wire September 14, 2023

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company's Boardroom

Business Wire September 6, 2023

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders

Business Wire August 25, 2023

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

Business Wire August 14, 2023

Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102

Business Wire August 1, 2023

Jasper Therapeutics Appoints Scott Brun, M.D., to its Board of Directors

GlobeNewswire June 20, 2023

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Business Wire May 19, 2023

Forte Biosciences, Inc. Announces First Quarter 2023 Results and Provides Business Update

Business Wire May 15, 2023

Forte Biosciences, Inc. Announces Full Year 2022 Results and Provides Business Update

Business Wire March 31, 2023

Mr. David Gryska Appointed to Forte Biosciences Board of Directors

Business Wire January 12, 2023

Dr. Scott Brun, M.D. Appointed to Forte Biosciences Board of Directors

Business Wire November 14, 2022